Florida Cancer Specialists & Research Institute Welcomes Dr. Mohammad K. Kamal
- October 2, 2017
- No responses
BROUGHT TO YOU BY A 100% FLASCO MEMBERSHIP PARTNER
New Physician Joins in Marion County
Ocala, FL – October 1, 2017… Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that Mohammad K. Kamal, MD has joined the statewide practice and is seeing patients at a new Ocala office of Florida Cancer Specialists, located at 2820 SE 3rd Court, Suite 200, Ocala, FL.
FCS CEO Brad Prechtl said, “We are delighted to welcome Dr. Kamal to Florida Cancer Specialists. He has established an excellent reputation in Marion County and will offer added convenience for our patients in Ocala. We are very pleased to have him join the FCS family.”
Dr. William Harwin, Founder and President of FCS, added, “Dr. Kamal has been practicing in the Ocala area for over thirty years and is known as a caring and compassionate physician. He is well-respected by both his peers and his patients and has provided leadership at several local hospitals. Dr Kamal will continue to practice at his current office, thus increasing the number of FCS clinics to three in Marion County.”
Dr. Mohammad Kamal attended medical school in Mosul, Iraq at the University of Mosul. After graduating, he relocated to Johnson City, Tennessee where he completed his Residency and Fellowship in Oncology/ Hematology at East Tennessee State University. Dr. Kamal has been practicing medical oncology in Marion County since 1985 and prior to joining Florida Cancer Specialists, he had a successful private practice in Ocala, FL. Currently, Dr. Kamal serves as a Board Member of Ocala Regional Medical Center and West Marion Community Hospital. Dr. Kamal is married with three children and enjoys golf, fishing, soccer and skiing.
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state’s leading hospitals.
FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Jacksonville/Fleming Island to Palm Beach County.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval